Pregnancy Trimester, Second

• 

  Subject Areas on Research

  • A prospective blinded comparison of second trimester fetal measurements by expert and novice readers using low-cost novice-acquired 3D volumetric ultrasound. 
  • Abdominal pregnancy: a report of two cases and review of the pathogenesis, diagnosis and treatment. 
  • Above-elbow arm replantation during pregnancy. 
  • Activin A and follistatin are dynamically regulated during human pregnancy. 
  • Acute abdomen caused by placenta percreta in the second trimester. 
  • Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. 
  • Associations of gestational cardiovascular health with pregnancy outcomes: the Hyperglycemia and Adverse Pregnancy Outcome study. 
  • Cervical priming prior to dilatation and evacuation: a comparison of methods. 
  • Cervical prolapse complicating pregnancy. 
  • Characteristics of uterine activity in gestations less than 20 weeks. 
  • Characterization of antithrombin levels in pregnancy. 
  • Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester. 
  • Combined serum and ultrasound screening for detection of fetal aneuploidy. 
  • Comparison of prostaglandin F2alpha and hypertonic saline for induction of midtrimester abortion. 
  • Complications of prenatal therapy with diethylstilbestrol. 
  • Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion. 
  • Correlates of intake of folic acid-containing supplements among pregnant women. 
  • Cyclophosphamide for lupus during pregnancy. 
  • Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. 
  • Detection of phytoestrogens in samples of second trimester human amniotic fluid. 
  • Dioxin-like activity and maternal thyroid hormone levels in second trimester maternal serum. 
  • Dysmorphologic features of the fetal pelvis in Down syndrome: prenatal sonographic depiction and diagnostic implications of the iliac angle. 
  • Factors Associated with Previable Delivery following Second Trimester Rupture of Membranes. 
  • Failure of angiotensin II to reduce plasma renin activity in hypertensive pregnant women. 
  • Fetal brain development of twins assessed in utero by ultrasound: implications for schizophrenia. 
  • First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes. 
  • First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation. 
  • Frequency and prediction of persistent urinary tract dilation in third trimester and postnatal urinary tract dilation in infants following diagnosis in second trimester. 
  • Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study. 
  • Histologic development of the human fovea from midgestation to maturity. 
  • Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%. 
  • In vitro sealing of punctured fetal membranes: potential treatment for midtrimester premature rupture of membranes. 
  • Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2alpha (THAM) suppositories. 
  • Integrase inhibitors in late pregnancy and rapid HIV viral load reduction. 
  • Management of failed prostaglandin abortions. 
  • Maternal PUFA status and offspring allergic diseases up to the age of 18 months. 
  • Maternal psychological distress, prenatal cortisol, and fetal weight. 
  • Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories. 
  • Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin E2 methyl ester. 
  • Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. 
  • Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm. 
  • Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha. 
  • Physical activity and sleep among pregnant women. 
  • Physical activity patterns during pregnancy. 
  • Placenta previa in the second trimester: sonographic and clinical factors associated with its resolution. 
  • Porencephaly secondary to fetal trauma during amniocentesis. 
  • Predicting gestational diabetes: choosing the optimal early serum marker. 
  • Predictors of measurement error in energy intake during pregnancy. 
  • Predictors of urinary flame retardant concentration among pregnant women. 
  • Predictors of vaginal bleeding during the first two trimesters of pregnancy. 
  • Pregnancy-associated group B streptococcal endocarditis: a report of two fatal cases. 
  • Prenatal anger effects on the fetus and neonate. 
  • Prenatal diagnosis and management of massive bilateral axillary cystic lymphangioma. 
  • Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. 
  • Previous cesarean section, placenta increta, and uterine rupture in second-trimester abortion. 
  • Prior cesarean and the risk for placenta previa on second-trimester ultrasonography. 
  • Regionally-specified second trimester fetal neural stem cells reveals differential neurogenic programming. 
  • Religiosity is an important part of coping with grief in pregnancy after a traumatic second trimester loss. 
  • Retinal vasculature and 5-year metabolic syndrome among women with gestational diabetes mellitus. 
  • Right frontal EEG and pregnancy/neonatal outcomes. 
  • Risk of preeclampsia in second-trimester triploid pregnancies. 
  • SMFM Fetal Anomalies Consult Series #3: Intracranial Anomalies. 
  • Second trimester folate status and preterm birth. 
  • Second-trimester ductus venosus measurement and adverse perinatal outcome in fetuses with congenital heart disease. 
  • Serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha in the induction of abortion. 
  • Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013). 
  • Stability of mood states and biochemistry across pregnancy. 
  • Stress and placental resistance measured by Doppler ultrasound in early and mid-pregnancy. 
  • Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. 
  • The abortifacient and oxytocic effects of an intravaginal silicone rubber device containing a 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester. 
  • The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. 
  • The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration. 
  • The fallacy of placental migration: effect of sonographic techniques. 
  • The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion. 
  • Third ventricle: size and appearance in normal fetuses through gestation. 
  • Thrombosis during pregnancy and the postpartum period. 
  • Urinary metabolites of organophosphate flame retardants and their variability in pregnant women. 
  • Utility of fetal echocardiogram in high-risk patients. 
  • Viable bacterial colonization is highly limited in the human intestine in utero. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology